Pathwork® Tissue of Origin Test for FFPE Cleared by
U.S. Food and Drug Administration
Molecular profiling test utilizes common clinical specimen type
to help identify cancers
REDWOOD CITY, Calif., June 15, 2010 – Pathwork Diagnostics Inc., a molecular diagnostics
company focused on oncology, today announced the U.S. Food and Drug Administration (FDA)
cleared the Pathwork® Tissue of Origin Test for formalin-fixed, …